Dr Reddys Laboratories Ltd Share Price Today - Live Blog for April 12, 2026

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 1.68%, reaching the current market price of 1232.20. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's shares saw an increase of 1.68%, reaching the current market price of 1232.20. This development underscores the stock's growing popularity.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 1.68% increase and currently trading at 1232.20 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd's shares experienced a 1.68% uptick, and they are currently valued at 1232.20, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277.

Dr Reddys Laboratories Ltd's shares experienced a 1.68% uptick, and they are currently valued at 1232.20, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277.

Demonstrating a commendable 1.68% gain, Dr Reddys Laboratories Ltd's share price is currently situated at 1232.20. In terms of valuation, the stock maintains a PE ratio of 18.6200, while the industry PE ratio stands at 31.9028.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 1.68% recently. As of now, this stock is actively trading at a current market price of 1232.20 per share, attracting attention from investors.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 1.68%, reaching the current market price of 1232.20. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 1.68%, reaching the current market price of 1232.20. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd experienced a substantial 1.68% boost in its share price and has garnered significant attention from the market. It's now trading at 1232.20, making it an appealing option for investors.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 1.68% gain, with the share price now at 1232.20. Notably, the stock's PE ratio stands at 18.6200, and its Return on Equity (ROE) is 16.0277.